Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2271021/compared-to-estimates-supernus-supn-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2271021
May 08, 2024 - The headline numbers for Supernus (SUPN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2232821/supernus-supn-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2232821
Feb 27, 2024 - Although the revenue and EPS for Supernus (SUPN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
https://www.zacks.com/stock/news/2228591/analysts-estimate-supernus-pharmaceuticals-supn-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2228591
Feb 20, 2024 - Supernus (SUPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Pages: 1
Page 1